Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Other Non-Current Liabilities (2024)

Historic Other Non-Current Liabilities for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Q2 2025 value amounting to $4.5 million.

  • Zhengye Biotechnology Holding's Other Non-Current Liabilities changed N/A to $4.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.5 million, marking a year-over-year change of. This contributed to the annual value of $4.5 million for FY2024, which is N/A changed from last year.
  • As of Q2 2025, Zhengye Biotechnology Holding's Other Non-Current Liabilities stood at $4.5 million.
  • In the past 5 years, Zhengye Biotechnology Holding's Other Non-Current Liabilities registered a high of $4.5 million during Q4 2024, and its lowest value of $4.5 million during Q2 2025.